The Catholic University of Korea St. Vincent's Hospital is a medical center in Suwon, South Korea. The number of beds is 900. Hospital is used in the 2010 TV series Master of Study.

There are 900 beds in The Catholic University of Korea, St. Vincent's Hospital.

During the past decade, The Catholic University of Korea, St. Vincent's Hospital conducted 168 clinical trials. In the 10-year time frame, 168 clinical trials started and 39 clinical trials were completed, i.e. on average, 23.2% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 34 clinical trials were completed. i.e. 48.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Catholic University of Korea, St. Vincent's Hospital" #1 sponsor was "The Catholic University of Korea" with 20 trials, followed by "Hoffmann-La Roche" with 18 trials sponsored, "Janssen Research & Development, LLC" with 11 trials sponsored, "Pfizer" with 9 trials sponsored and "Celgene" with 9 trials sponsored. Other sponsors include 126 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Catholic University of Korea, St. Vincent's Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 6 trials as a collaborator, "Gilead Sciences" with 5 trials as a collaborator, "Korean Cancer Study Group" with 4 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator and "Merck Sharp & Dohme LLC" with 4 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "The Catholic University of Korea, St. Vincent's Hospital" are "Ulcerative Colitis" (18 trials), "Crohn's Disease" (9 trials), "Coronary Artery Disease" (8 trials), "Crohn Disease" (7 trials) and "Non-Small Cell Lung Cancer" (7 trials). Many other conditions were trialed in "The Catholic University of Korea, St. Vincent's Hospital" in a lesser frequency.

Most popular intervention types in "The Catholic University of Korea, St. Vincent's Hospital" are "Drug" (134 trials), "Biological" (25 trials), "Other" (19 trials), "Device" (18 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Cisplatin" (12 trials), "Carboplatin" (11 trials), "Atezolizumab" (10 trials) and "Pemetrexed" (10 trials). Other intervention names were less common.

The vast majority of trials in "The Catholic University of Korea, St. Vincent's Hospital" are 193 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are 83 active trials in "The Catholic University of Korea, St. Vincent's Hospital". 1 are not yet recruiting, 48 are recruiting, 33 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 70 completed trials in The Catholic University of Korea, St. Vincent's Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in The Catholic University of Korea, St. Vincent's Hospital, 21 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 23 trials that are defined as “Not Applicable".